Baakwa De-Graft Miah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Baakwa De-Graft Miah has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Addo Stephen Tetteh
West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Legon, Accra, Ghana
1 shared publication - Adwoa Ayewa Ayimadu
West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Legon, Accra, Ghana
1 shared publication - Alice Boakyewaa1 shared publication
- Anjali Rathod
West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Legon, Accra, Ghana
1 shared publication - Arnold Abakah
Kumasi Centre for Collaborative Research in Tropical Medicine Kwame Nkrumah University of Science and Technology Kumasi Ghana
1 shared publication - Daniel Baah
West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana, Legon, Accra, Ghana
1 shared publication
Latest Publications
- Open Access
Policy-Enforced Genomic Repositories and Institutional Data Governance for African Pathogen Surveillance with UbuntuBio
Research centers curating pathogen sequence cohorts often operate under constrained bandwidth, multi-institutional data-sharing agreements, and strict biosafety requirements. Global public archives keep released sequences permanently open, external viral portals enforce terms outside local institutional custody, and standard Git Large File Storage (LFS) duplicates identical binaries across repositories without validating taxonomy or geography. We present UbuntuBio (v1.0.0), a Git-native, policy-enforced genomic repository platform deployed at https://ubuntubio.org and developed at the West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana. UbuntuBio integrates four mechanisms under a single storage root: (1) bare Git repositories storing dataset cards, sample sheets, and approximately 130-byte LFS pointers backed by prefix-sharded SHA-256 content-addressed storage (CAS) with visibility-scoped wire deduplication; (2) a four-phase commit pipeline recoverable via cross-plane reconciliation that enforces 55 African Union country codes against offline Natural Earth polygons, core MIxS-derived fields, Taxon 9606 rejection, and server-keyed targeted human-marker screening identically across HTTP commits and Git pre-receive hooks; (3) institutional custody controls combining Data Use Agreements (DUAs), revocable 900-second RS256 capability tokens, key rotation, tamper-evident hash-chained logs, and externally anchorable RS256 audit checkpoints; and (4) an embedded SQLite WAL and FTS5 catalog filtered by access tier. In single-node evaluation, UbuntuBio classified 18/18 policy boundary fixtures consistently across Python, Git, and HTTP paths; showed 0/265,157 false cross-matches on 21/22 RefSeq pathogen sequences (while cross-matching Candida albicans 18S rDNA at 0.113% and Chlorocebus sabaeus Alu repeats in ENA stool reads, confirming targeted marker detection rather than verified human DNA decontamination); matched conditional uniform (n = 2,000; 200-seed 0.01% convergence 19.0% vs. 18.13% expected) and interior (n = 1,000) detection theory while detecting all spike-ins at ≥ 0.5% (30/30); halved two-repository disk usage on 613.83 MiB Nigerian E. coli runs; passed 27/27 structured-filter correctness checks over 10,000 biosamples and reached graded NDCG@10 = 0.920 on independent free-text BM25 queries with zero private leaks; and recovered cleanly across seven injected phase-transition faults.
Open AccessPolicy-Enforced Genomic Repositories and Institutional Data Governance for African Pathogen Surveillance with UbuntuBio
Research centers curating pathogen sequence cohorts often operate under constrained bandwidth, multi-institutional data-sharing agreements, and strict biosafety requirements. Global public archives keep released sequences permanently open, external viral portals enforce terms outside local institutional custody, and standard Git Large File Storage (LFS) duplicates identical binaries across repositories without validating taxonomy or geography. We present UbuntuBio (v1.0.0), a Git-native, policy-enforced genomic repository platform deployed at https://ubuntubio.org and developed at the West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana. UbuntuBio integrates four mechanisms under a single storage root: (1) bare Git repositories storing dataset cards, sample sheets, and approximately 130-byte LFS pointers backed by prefix-sharded SHA-256 content-addressed storage (CAS) with visibility-scoped wire deduplication; (2) a four-phase commit pipeline recoverable via cross-plane reconciliation that enforces 55 African Union country codes against offline Natural Earth polygons, core MIxS-derived fields, Taxon 9606 rejection, and server-keyed targeted human-marker screening identically across HTTP commits and Git pre-receive hooks; (3) institutional custody controls combining Data Use Agreements (DUAs), revocable 900-second RS256 capability tokens, key rotation, tamper-evident hash-chained logs, and externally anchorable RS256 audit checkpoints; and (4) an embedded SQLite WAL and FTS5 catalog filtered by access tier. In single-node evaluation, UbuntuBio classified 18/18 policy boundary fixtures consistently across Python, Git, and HTTP paths; showed 0/265,157 false cross-matches on 21/22 RefSeq pathogen sequences (while cross-matching Candida albicans 18S rDNA at 0.113% and Chlorocebus sabaeus Alu repeats in ENA stool reads, confirming targeted marker detection rather than verified human DNA decontamination); matched conditional uniform (n = 2,000; 200-seed 0.01% convergence 19.0% vs. 18.13% expected) and interior (n = 1,000) detection theory while detecting all spike-ins at ≥ 0.5% (30/30); halved two-repository disk usage on 613.83 MiB Nigerian E. coli runs; passed 27/27 structured-filter correctness checks over 10,000 biosamples and reached graded NDCG@10 = 0.920 on independent free-text BM25 queries with zero private leaks; and recovered cleanly across seven injected phase-transition faults.
- Open Access
- 1 January 2026
- Published by Wiley in Advances in Public Health
- Vol. 2026 (1)
IFN‐ γ Levels and Indeterminate Rate: Comparative Analysis of Three Commercial Interferon‐Gamma Release Assays for Diagnosis of Mycobacterium tuberculosis Infection
Background: The diagnosis of Mycobacterium tuberculosis infection increasingly relies on interferon‐gamma release assay (IGRA) technologies. Despite their usefulness, inconsistency in IFN‐ γ responses and the persistence of indeterminate results remain problematic across IGRA platforms. The present study aimed to comparatively assess three commercial IGRA assays (TBF‐ELISA, TBF‐FIA, and QFT‐Plus) with emphasis on IFN‐ γ production and factors influencing indeterminate results. Methods: The study employed a cross‐sectional design and was implemented at the National Public Health and Reference Laboratory in Ghana. A total of 1148 individuals were enrolled consecutively and stratified according to their TB exposure status. Parallel testing of collected blood samples was performed with the three IGRA assays. IFN‐ γ production was quantified, and the rate of indeterminate results was analyzed. Multivariate regression analyses were performed to assess determinants of IFN‐ γ levels and indeterminate results. Results: Significant quantitative differences in IFN‐ γ responses were observed across platforms ( p < 0.001). Active TB was the strongest predictor of IFN‐ γ release, with highest mean levels detected by TBF‐FIA (6.18 IU/mL), followed by TBF‐ELISA (3.11 IU/mL) and QFT‐Plus (2.80–2.96 IU/mL). TBF‐ELISA showed strong concordance with minimal bias versus QFT‐Plus (≤0.167 IU/mL), whereas TBF‐FIA demonstrated substantial proportional bias (>1.5 IU/mL). Indeterminate rates differed significantly (TBF‐FIA 13%, QFT‐Plus 8%, TBF‐ELISA 6%; Cochran’s Q test, p < 0.001). Demographic factors were not associated with assay failure; however, sample collection sites were significantly related. Notably, healthcare workers and TB contacts showed lower IFN‐ γ responses than expected. Conclusion: While all three IGRAs effectively differentiate TB infection status, the variability in IFN‐ γ responses and indeterminate rates is an indication that they may not be interchangeable. TBF‐FIA demonstrated the highest variability, requiring further investigation. The findings suggest that each test has its own strengths and limitations, thus, the need for selective use depending on the clinical setting and testing purpose.
- 1 January 2026
- Published by Wiley in Advances in Public Health
- Vol. 2026 (1)
Open AccessIFN‐ γ Levels and Indeterminate Rate: Comparative Analysis of Three Commercial Interferon‐Gamma Release Assays for Diagnosis of Mycobacterium tuberculosis Infection
Background: The diagnosis of Mycobacterium tuberculosis infection increasingly relies on interferon‐gamma release assay (IGRA) technologies. Despite their usefulness, inconsistency in IFN‐ γ responses and the persistence of indeterminate results remain problematic across IGRA platforms. The present study aimed to comparatively assess three commercial IGRA assays (TBF‐ELISA, TBF‐FIA, and QFT‐Plus) with emphasis on IFN‐ γ production and factors influencing indeterminate results. Methods: The study employed a cross‐sectional design and was implemented at the National Public Health and Reference Laboratory in Ghana. A total of 1148 individuals were enrolled consecutively and stratified according to their TB exposure status. Parallel testing of collected blood samples was performed with the three IGRA assays. IFN‐ γ production was quantified, and the rate of indeterminate results was analyzed. Multivariate regression analyses were performed to assess determinants of IFN‐ γ levels and indeterminate results. Results: Significant quantitative differences in IFN‐ γ responses were observed across platforms ( p < 0.001). Active TB was the strongest predictor of IFN‐ γ release, with highest mean levels detected by TBF‐FIA (6.18 IU/mL), followed by TBF‐ELISA (3.11 IU/mL) and QFT‐Plus (2.80–2.96 IU/mL). TBF‐ELISA showed strong concordance with minimal bias versus QFT‐Plus (≤0.167 IU/mL), whereas TBF‐FIA demonstrated substantial proportional bias (>1.5 IU/mL). Indeterminate rates differed significantly (TBF‐FIA 13%, QFT‐Plus 8%, TBF‐ELISA 6%; Cochran’s Q test, p < 0.001). Demographic factors were not associated with assay failure; however, sample collection sites were significantly related. Notably, healthcare workers and TB contacts showed lower IFN‐ γ responses than expected. Conclusion: While all three IGRAs effectively differentiate TB infection status, the variability in IFN‐ γ responses and indeterminate rates is an indication that they may not be interchangeable. TBF‐FIA demonstrated the highest variability, requiring further investigation. The findings suggest that each test has its own strengths and limitations, thus, the need for selective use depending on the clinical setting and testing purpose.